Shi Gao Liu
Keine laufenden Positionen mehr
Vermögen: 5 Mio $ am 30.04.2024
Karriereverlauf von Shi Gao Liu
Ehemalige bekannte Positionen von Shi Gao Liu
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SHANGHAI HENLIUS BIOTECH, INC. | Director/Board Member | - | 30.09.2020 |
| Chief Executive Officer | 01.12.2009 | 30.09.2020 | |
| Founder | 01.12.2009 | 30.09.2020 | |
| President | 01.12.2009 | 19.02.2020 | |
Henlius Biopharmaceuticals, Inc.
 Henlius Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Henlius Biopharmaceuticals, Inc. focuses on development and commercialization of mAb-based therapeutics biosimilars and biobetter for malignant tumors and auto-immune diseases. The company was founded by Scott Liu and Paul Liu in 2009 and is headquartered in Fremont, CA. | Chief Executive Officer | 01.01.2009 | - |
| Founder | 01.01.2009 | - | |
| President | 01.01.2009 | - |
Ausbildung von Shi Gao Liu
| Purdue University | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 3 |
| China | 2 |
Operativ
| Chief Executive Officer | 2 |
| Founder | 2 |
| President | 2 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SHANGHAI HENLIUS BIOTECH, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Henlius Biopharmaceuticals, Inc.
Henlius Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Henlius Biopharmaceuticals, Inc. focuses on development and commercialization of mAb-based therapeutics biosimilars and biobetter for malignant tumors and auto-immune diseases. The company was founded by Scott Liu and Paul Liu in 2009 and is headquartered in Fremont, CA. | Health Technology |
- Börse
- Insiders
- Shi Gao Liu
- Erfahrung
